DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Richardson PG, Sonneveld P, Schuster MW et al.
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.
Br J Haematol 2009;
144: 895-903
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.